Association between interleukin-22 genetic polymorphisms and bladder cancer risk

Authors

  • Tao Zhao Chongqing Medical University; Department of Urology; YongChuan Hospital
  • XiaoHou Wu Medical University; Department of Urology; The First Affiliated Hospital of Chongqing
  • JiaJi Liu Chongqing Medical University; Department of Urology; YongChuan Hospital

DOI:

https://doi.org/10.6061/clinics/2015(10)05

Abstract

OBJECTIVE:The cytokine interleukin-22 (IL-22), which is produced by T cells and natural killer cells, is associated with tumorigenesis and tumor progression in cancers. However, the role of IL-22 in bladder cancer has not been investigated.MATERIALS AND METHODS:A prospective hospital-based case-control study comprising 210 patients with pathologically proven bladder cancer and 210 age- and gender-matched healthy controls was conducted. The genotypes of 3 common polymorphisms (-429 C/T, +1046 T/A and +1995 A/C) of the IL-22 gene were determined with fluorogenic 5' exonuclease assays.RESULTS:Patients with bladder cancer had a significantly higher frequency of the IL-22 -429 TT genotype [odds ratio (OR)=2.04, 95% confidence interval (CI)=1.19, 3.49; p=0.009] and -429 T allele (OR=1.42, 95% CI=1.08, 1.87; p=0.01) than the healthy controls. These findings were still significant after a Bonferroni correction. When stratifying according to the stage of bladder cancer, we found that patients with superficial bladder cancer had a significantly lower frequency of the IL-22 -429 TT genotype (OR=0.48, 95% CI=0.23, 0.98; p=0.04). When stratifying according to the grade and histological type of bladder cancer, we found no statistical association. The IL-22 +1046 T/A and IL-22 +1995 A/C gene polymorphisms were not associated with the risk of bladder cancer.CONCLUSION:To the authors' knowledge, this is the first report documenting that the IL-22 -429 C/T gene polymorphism is associated with bladder cancer risk. Additional studies are required to confirm this finding.

Downloads

Download data is not yet available.

Downloads

Published

2015-10-01

Issue

Section

Clinical Sciences

How to Cite

Zhao, T., Wu, X., & Liu, J. (2015). Association between interleukin-22 genetic polymorphisms and bladder cancer risk . Clinics, 70(10), 686-690. https://doi.org/10.6061/clinics/2015(10)05